Paragon Care Limited · ASX:PGC
Paragon Care — Shareholder Meeting (November 2016)
16 slides from Paragon Care's shareholder meeting presentation, Nov 18, 2016
Slide 1: Paragon Care Limited – 2016 Annual General Meeting Chairman's Address and Presentation
ASX ANNOUNCEMENT paragoncare.com.au 18 November 2016 Australian Securities Exchange Company Announcements Office PARAGON CARE LIMITED – 2016 ANNUAL GENERAL MEETING CHAIRMAN’S ADDRESS AND PRESENTATION Paragon Care Limited (“Company”) is convening its 2016 Annual General Meeting today, 18 November 201
Slide 2: Chairman's Address – 2016 Annual General Meeting
18 November 2016 Australian Securities Exchange Company Announcements Office CHAIRMAN’S ADDRESS – 2016 ANNUAL GENERAL MEETING Good morning ladies and gentlemen. Welcome to the 2016 annual general meeting of Paragon Care. My name is Shane Tanner and I am the chairman of the company. Thank you for you
Slide 3: Chairman's address: acquisitions, FY17 start and strategy
The Company undertook a capital raising in October 2015 which was heavily oversubscribed to raise $47m to fund the acquisition of Designs for Vision, Western Biomedical and Meditron. In the current financial year two key acquisitions have been made – MIDAS and Electro Medical were completed in July
Slide 4: AGM Presentation 18 November 2016
AGM Presentation 18 November 2016 ASX: PGC
Slide 5: Agenda
Agenda A low-risk exposure to a rapidly growing health care company Company Highlights Vision and Strategy Corporate Overview FY16 Results Summary Recent Acquisitions Trading Update New Products Share Price Catalysts Growth in FY17, FY18 and Beyond Disclaimer Paragon Care Limited (ASX: PGC) 2|
Slide 6: Company Highlights
Company Highlights A low-risk exposure to a rapidly growing health care company Paragon is one of the premier medical equipment, device and consumables suppliers on the ASX Platform economics, extensive distribution networks and a customer-focused business model Favourable macro tailwinds given the
Slide 7: Vision and Strategy
Vision and Strategy Paragon’s vision is to be Australia’s leading supplier of medical equipment, devices and consumables Market Market Strategy characteristics opportunity To create a healthcare platform Highly fragmented industry, Paragon Care to maximise the with a valuable range of characterised
Slide 8: Corporate Overview
Corporate Overview Highly aligned Board and management team with a long term, supportive shareholder base Board of Directors Financial Information Shane Tanner Mark Simari Non-Executive Chairman Managing Director / CEO Share price (16-Nov-2016) $0.88 Chairman of Zenitas Healthcare Limited and Extens
Slide 9: FY16 Results Summary
FY16 Results Summary FY16 was a record year for Paragon, with FY17 expected to show strong growth Revenue Net profit after tax Operating cash flow $93.4m $7.5m $7.8m up 190% 2015: $32.2m up 257% 2015: $2.1m up 858% 2015: $0.8m Gross profit Earnings per share Cash $36.5m 5.6c $19.1m up 135% 2015: $15
Slide 10: FY16 Results Summary
FY16 Results Summary FY16 was a record year for Paragon, with FY17 expected to show strong growth Financial highlights Record results across all key metrics — Revenue up 190% to $93.4m; EBITDA up 227% to $12.1m; NPAT up 257% to $7.5m Strong balance sheet and operating cash flows up 858% to $7.8m Str
Slide 11: Recent Acquisitions
Recent Acquisitions The recent acquisitions of MIDAS and Electro Medical were both funded internally through operating cash flows and represent significant upside potential to Paragon’s long term earnings Acquisition completed on 6th July 2016 Acquisition completed on 7th October 2016 MIDAS is a wor
Slide 12: Trading Update
Trading Update Paragon has enjoyed a strong start to FY17, with several key internal milestones achieved and strong growth seen across key financial metrics In the first quarter of FY17, the company’s EBITDA on a like for like basis is 12% up over the prior corresponding quarter1 and we are on track
Slide 13: New Products
New Products Exciting new products in FY17 should drive additional new revenue streams Rubbermaid Stralus Aged Care Beds Rubbermaid Healthcare is a recognised leader in the Class-leading aged care bed developed internally following development and manufacture of medical carts an extensive R&D progra
Slide 14: Share Price Catalysts
Share Price Catalysts Continued operational outperformance should support attractive risk-adjusted returns SYNERGIES Continue to leverage platform economics to drive organic revenue growth Platform economics by accessing new geographies, extending market reach and pursuing additional cross-selling a
Slide 15: Growth in FY17, FY18 and Beyond
Growth in FY17, FY18 and Beyond Strong long-term growth focus with proven execution Paragon has a proven track record of strong organic growth and growth through sensible acquisitions Target revenue Shareholders have benefited from strong share price increases and the payment of fully franked divide
Slide 16: Thank You / Disclaimer
THANK YOU DISCLAIMER Some of the statements in this presentation constitute “forward-looking statements” that do not directly or exclusively relate to historical facts. These forward-looking statements reflect Paragon Care Limited’s current intentions, plans, expectations, assumptions and beliefs ab